EV/EBITDA
-0.36
0.000.00%
Thu, 28 Nov 2024 00:26:17 GMT
Summary:
Lyra Therapeutics EV/EBITDA is currently -0.36, unchanged from the previous trading day. Over the past year, it has increased by +2.28 (+86.36%). LYRA EV/EBITDA is now -162.07% below its all-time high of 0.58.LYRA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | 0.0% |
1 m1 month | +14.3% |
3 m3 months | 0.0% |
6 m6 months | +39.0% |
ytdytd | +92.1% |
1 y1 year | +86.4% |
5 y5 years | - |
LYRA EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -0.34 | -5.9% | -0.45 | +20.0% |
3 m | 3 months | -0.28 | -28.6% | -0.45 | +20.0% |
6 m | 6 months | -0.28 | -28.6% | -0.59 | +39.0% |
1 y | 1 year | -0.28 | -28.6% | -5.85 | +93.8% |
3 y | 3 years | 0.58 | -162.1% | -5.85 | +93.8% |
5 y | 5 years | 0.58 | -162.1% | -11.57 | +96.9% |
alltime | all time | 0.58 | -162.1% | -11.57 | +96.9% |
Lyra Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -0.36(-92.1%) |
2023 | -4.58(+249.6%) |
Date | Value |
---|---|
2022 | -1.31(+351.7%) |
2021 | -0.29(-91.5%) |
2020 | -3.40 |
FAQ
- What is Lyra Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lyra Therapeutics?
- What is LYRA EV/EBITDA year-to-date change?
- What is Lyra Therapeutics EV/EBITDA year-on-year change?
What is Lyra Therapeutics EV/EBITDA?
The current EV/EBITDA of LYRA is -0.36
What is the all time high EV/EBITDA for Lyra Therapeutics?
Lyra Therapeutics all-time high EV/EBITDA is 0.58
What is LYRA EV/EBITDA year-to-date change?
Lyra Therapeutics EV/EBITDA has changed by +4.22 (+92.14%) since the beginning of the year
What is Lyra Therapeutics EV/EBITDA year-on-year change?
Over the past year, LYRA EV/EBITDA has changed by +2.28 (+86.36%)